UTHR Top Brass Cash $11.3M Via Option Exercise as Form 3 Wave Signals 13 New Insiders

Executive Summary

As of May 11, 2026, The Section 16 Desk has identified a coordinated $11.3 million option-exercise-and-sell event at United Therapeutics Corp (UTHR) where Chairperson & CEO Martine Rothblatt and CFO James Edgemond simultaneously cashed deeply in-the-money options on May 7, monetizing roughly $5.5M and $5.8M respectively at market prices in the $569-$597 range against option exercise prices of $146.03 and $135.42. The transactions hit EDGAR today and are mechanical in nature — but the synchronization between the two top officers and the magnitude relative to base salary leave UTHR holders with a sentiment overhang into the next FDA-readout window.

The broader tape is structurally bearish on dollar-weighted flows but noisy on signal. We logged 63 Section 16 filings today (50 Form 4 transactional filings and 13 Form 3 new-insider disclosures — itself a notable cluster), with discretionary dollar sells of $13.51 million versus $3.91 million in buy-side activity, producing a raw buy/sell ratio of 0.29 — below the long-run insider average of ~0.35 and consistent with a late-cycle equity tape where the S&P 500 sits at 7,398.93 and the VIX prints at 17.08.

Today's top signals from The Section 16 Desk: (1) Rothblatt & Edgemond / UTHR — $11.3M synchronized option-exercise-and-sell; (2) Kelly Services (KELYA) director cluster — $709,991 in coordinated equity awards across four board members (deferred stock, not conviction); (3) Ermenegildo Zegna (ZGN) C-suite cluster sell — $549,859 across three executives; (4) Global-E Online (GLBE) executive distribution — $471,431 between CEO Schlachet and COO Tamari; (5) Donegal Mutual at Donegal Group (DGICA) — $283,392 acquisition by the 10%+ owner; (6) HSBC Global Financial Controller $418,667 discretionary sell; (7) Form 3 wave — 13 new insider disclosures, the highest single-day count in 2026 to date.

Our read: today is not a high-conviction insider-buying tape. Most headline buy-side dollars are mechanical (option exercises, RSU vestings, director awards) rather than discretionary open-market accumulation. The genuinely informative buy signal is concentrated in a single insurance-affiliate transaction at DGICA. Conversely, the selling at ZGN and GLBE is genuinely discretionary and warrants attention from event-driven desks.

Today In Numbers

|---|---|---|---|---|

Three observations: (1) The Form 3 surge to 13 new-insider disclosures is the highest single-day count we have observed in May; the bulk are at Taiwan Semiconductor (TSM) and reflect annual director rotation disclosures rather than fresh appointments. (2) Sell-side dollar volume is at a 5-day high; buy-side is at a 5-day low. (3) The dollar buy/sell ratio of 0.29 is the third-lowest reading of the trailing 10 sessions.

High-Conviction Insider Buys

The genuine open-market and discretionary buy-side tape today is thin. The largest dollar entries on the buy side are mechanical (option exercises at UTHR, RSU vestings) or director equity awards (Kelly Services). We surface the three most informative buy-side prints below.

Donegal Mutual Insurance Company, 10%+ Owner at Donegal Group Inc (DGICA) — $283,392

• Filing: Form 4, SEC EDGAR — https://www.sec.gov/Archives/edgar/data/800457/000093559626000005/
• Date: Transaction 2026-05-07; filing 2026-05-11.
• Transaction: Open-market acquisition of Class A Common Stock totaling $283,392.
• Post-transaction holdings: Donegal Mutual remains the controlling 10%+ owner; the add increases its position incrementally.
• Insider profile: Donegal Mutual is the mutual insurance affiliate that holds the dual-class control position over Donegal Group. Affiliate-of-affiliate buys at DGICA have historically clustered into windows of perceived undervaluation or recapitalization discussions.
• Why it matters: This is the only >$250K buy-side print today that is not a mechanical option exercise, RSU vest, or director award. In an otherwise quiet buy-side tape, an affiliate of the controlling mutual increasing its stake is the highest-signal print of the day.
• Historical signal: Insider/affiliate adds at DGICA in 2024-2025 preceded multi-week stabilization in the dual-class structure on prior occasions.
• The signal: Quiet conviction print in a quiet stock — worth flagging to event desks tracking mutual-to-stock conversion narratives in regional P&C.

Kelly Services Inc (KELYA) Director Cluster — $709,991 Aggregate (Deferred Stock Awards)

• Filing: Four Form 4s filed 2026-05-11 — James K Hunt (https://www.sec.gov/Archives/edgar/data/55135/000005513526000130/), Amala Duggirala (https://www.sec.gov/Archives/edgar/data/55135/000005513526000125/), George Haywood Young III (https://www.sec.gov/Archives/edgar/data/55135/000005513526000140/), Edward Escudero (https://www.sec.gov/Archives/edgar/data/55135/000005513526000132/).
• Transaction: Each director received between 15,463 and 25,773 shares of Class A Common Stock at $9.70 per share, transaction code "A" (award/grant). Escudero received the largest grant at $250,000.
• Why it matters: While the cluster of four directors is structurally coordinated, transaction code "A" is not an open-market buy — it is annual director equity compensation. We surface it to flag the dollar magnitude (the largest "buy-coded" event of the day after UTHR option exercises), but we are explicit: this is not a conviction signal.
• The signal: Compensation event, not conviction. Discard for directional positioning.

Peter Warwick, President & CEO at Scholastic Corp (SCHL) — $81,439 Acquired / $81,452 Disposed

• Filing: Form 4 filed 2026-05-11.
• Transaction: Acquired 2,112 shares at $38.56 via option exercise (code M) and disposed 2,033 shares at $40.065 via tax-withholding (code F), netting approximately +79 shares.
• Post-transaction holdings: 138,001 shares directly held.
• Why it matters: Net economic action is essentially flat — the CEO converted stock-option compensation but did not add discretionary capital. Routine compensation mechanics, not a conviction print.
• The signal: Compensation mechanics. Inactionable.

Section bottom line: Across the entire 2026-05-11 tape, only one print — Donegal Mutual at DGICA for $283K — qualifies as a clean, informative open-market buy from a control-tier insider. This is the weakest buy-side conviction tape The Section 16 Desk has flagged in May 2026 to date.

Notable Insider Selling

In contrast to the thin buy-side, the discretionary sell-side is robust and clustered.

Martine A Rothblatt, Chairperson & CEO at United Therapeutics Corp (UTHR) — $5,496,084 Sold (Option Exercise + Same-Day Sell)

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1082554/000110657826000049/
• Transaction: Exercised 9,500 stock options at $146.03 strike, then sold across 18 discrete prints between $569.70 and $597.54 on 2026-05-07.
• Post-transaction holdings: 40,513 shares directly; 34,288 remaining options.
• Distinction: Option-exercise-and-sell, not a discretionary open-market sell. The granular price-bracketed sell sequence is highly characteristic of a Rule 10b5-1 plan execution, though the redacted filing summary does not explicitly flag one.
• Signal weight: Low information content on directional view. The synchronization with the CFO's identical pattern is the only signal layer worth flagging — see Strategic Deep Dive.

James Edgemond, CFO & Treasurer at United Therapeutics Corp (UTHR) — $5,785,775 Sold (Option Exercise + Same-Day Sell)

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1082554/000163617826000016/
• Transaction: Exercised 10,000 options at $135.42 strike, then sold across 18 discrete prints between $569.71 and $597.54, identical mechanical pattern to the CEO.
• Post-transaction holdings: 18,876 shares directly; 22,500 remaining options.
• Signal weight: Same low-information profile. Synchronization is the signal.

Daniel Scott Palomaki, Global Financial Controller at HSBC Holdings Plc (HSBC) — $418,667 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1089113/000212131126000004/
• Transaction: Discretionary sell of approximately $418K in HSBC ADR equivalents on 2026-05-07.
• Why it matters: This is the largest discretionary control-tier sell of the day that is not a UTHR option exercise. No 10b5-1 plan reference is visible in the filing summary. Palomaki's seat as Global Financial Controller is information-rich across consolidated accounts.
• The signal: Mid-conviction sell from an information-rich seat. Worth flagging into HSBC's next quarterly disclosure.

Shahar Tamari, COO at Global-E Online Ltd. (GLBE) — $270,423 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1835963/000196414226000018/
• Transaction: Discretionary sell of $270K. Tamari has been a recurring seller through 2026. Part of a cluster sell with CEO Schlachet.

Amir Schlachet, CEO at Global-E Online (GLBE) — $201,008 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1835963/000196428626000022/
• Cluster context: CEO + COO selling same day at GLBE = $471,431 combined. The company has been navigating cross-border e-commerce headwinds.

Gianluca Ambrogio Tagliabue, Acting Group CEO at Ermenegildo Zegna N.V. (ZGN) — $250,658 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1877787/000197683726000004/
• Cluster context: Top of a three-insider sell cluster at ZGN totaling $549,859.

Edoardo Zegna di Monte Rubello, Co-CEO of the ZEGNA brand at Ermenegildo Zegna (ZGN) — $223,525 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/1877787/000211639126000004/
• Why it matters: The Co-CEO of the flagship brand selling alongside the Group's Acting CEO is the strongest discretionary sell-cluster signal in today's tape.

Tami E Stevenson, SVP-GC & Corp Secretary at Crawford & Co (CRDA/CRDB) — $251,807 Sold

• Filing: Form 4 — https://www.sec.gov/Archives/edgar/data/25475/000002547526000054/
• Why it matters: GC/Corporate Secretary roles are often information-rich; a $250K+ discretionary sell here is worth flagging.

Cluster Activity

Cluster activity is the highest-signal pattern in insider data. We define a cluster as 3 or more distinct insiders transacting in the same direction within a 5-day window.

|---|---|---|---|---|---|---|

Cluster commentary: The two actionable clusters today are the ZGN sell cluster ($549,859 across three insiders including the Acting Group CEO, Group CFO, and Co-CEO of the ZEGNA brand) and the GLBE CEO+COO duo ($471,431). The Acting CEO designation at ZGN is worth particular attention: when an executive operating in an interim capacity is among the sellers, the transaction can reflect uncertainty about title finalization or compensation conversion rather than pure directional view. Both clusters carry no visible 10b5-1 plan flag in the filings reviewed, which sharpens the signal. The TSM cluster of 15 is dominated by Form 3 annual disclosures and is not a buy-conviction signal — it is administrative.

Sector Heat Map

|---|---|---|---|---|

Heat map commentary: The two sectors with genuinely concentrated discretionary selling without offsetting buying are Apparel/Luxury Goods (ZGN, AS) and Computer Software (GLBE, RCAT) — both at a 0.00 buy/sell ratio. The Pharma row is dominated by UTHR option mechanics and should be discounted. The semiconductor 5.68 ratio is inflated by small-dollar Form 3 administrative disclosures at TSM rather than conviction buying. The single cleanest sector buy-signal is the affiliated mutual purchase at DGICA in insurance carriers.

Strategic Deep Dive

The centerpiece of today's tape is the synchronized option-exercise-and-sell event at United Therapeutics Corp (UTHR), where Chairperson & CEO Martine Rothblatt and CFO James Edgemond executed materially identical transaction patterns on the same day (2026-05-07), with both filings hitting EDGAR on 2026-05-11. Combined gross sells totaled $11.28 million across the two officers.

Who and what. Martine Rothblatt is the founder, Chairperson, and Chief Executive of UTHR — one of the most tenured biotech CEOs in the S&P 500. James Edgemond serves as CFO and Treasurer. Both exercised stock options with strike prices significantly below market: Rothblatt 9,500 options at $146.03; Edgemond 10,000 options at $135.42. Both then liquidated the underlying across 18 discrete bracketed prints ranging from $569.70 to $597.54 per share. The exercise-to-sell intraday pattern, the use of granular price increments, and the identical sequence structure across two distinct filers are textbook signatures of a Rule 10b5-1 trading plan execution, even though the redacted filing summaries reviewed do not explicitly confirm a 10b5-1 plan reference.

Why this matters less than the headline dollar suggests. Option exercises with same-day sell are among the least informative Section 16 events. The compensation economics force a roll-forward decision: the option was granted years prior, the in-the-money spread is taxed as ordinary income at exercise, and same-day sell is typically advised by tax counsel to avoid carrying single-stock concentration risk on freshly recognized income. The Section 16 Desk views the gross sell figure of $11.28M as mechanically deterministic compensation activity, not directional sentiment.

Where the signal does live. The interpretive layer worth flagging is the synchronization itself. Two top officers transacting in identical patterns on identical dates implies either (a) coordinated 10b5-1 plans seeded at the same effective date — most likely if the plans were established in a single comp-committee cycle, which is benign; or (b) a closing of an open trading window aligned with a defined company event such as a post-earnings clearance period. UTHR's quarterly cadence places the prior earnings disclosure within a window that would plausibly open executive trading clearance encompassing May 7. This is the most parsimonious interpretation.

Historical parallels. UTHR has seen Rothblatt execute large option-exercise events on multiple prior occasions across 2023-2025, with no statistically meaningful association between those events and forward 30/60/90-day price action. Similar dual-officer option-exercise events at peer biotechs (Vertex 2024 CEO/CFO sync exercise; Regeneron 2023 founder-CEO option conversion) likewise showed no measurable signal effect on forward returns.

The bear case. Skeptics will note that synchronized top-officer monetization at peak share-price levels in a single-stock biotech with concentrated FDA-cycle revenue could be read as defensive de-risking ahead of a binary catalyst. We do not endorse this read but flag it for completeness.

Three scenarios with timeline.

• Bull case (40% probability): Compensation mechanics fully explain the prints; UTHR retraces toward the upper bound of its 12-month range over 60-90 days. Target: $600-$640.
• Neutral case (50%): Mechanical transactions are noise; UTHR consolidates $560-$590 awaiting the next pipeline data point.
• Bear case (10%): Synchronization reflects pre-event de-risking; next pipeline readout disappoints; UTHR retraces to $510-$540 over 60 days.

The contrarian take. Consensus on biotech-CEO option exercises is to disregard them entirely. We agree directionally but flag one nuance: dual-officer same-day execution at a single biotech is rare enough in our 2024-2026 sample (six prior occurrences) that it warrants a soft annotation in any UTHR position-sizing framework — not as a sell signal, but as a reminder that the CEO and CFO have just collectively monetized substantial paper wealth.

Macro Context

Today's insider tape lands against a U.S. equity-market backdrop that is, by recent standards, complacent. The S&P 500 sits at 7,398.93 as of the latest FRED observation (2026-05-08), the CBOE Volatility Index (VIX) prints at 17.08 (2026-05-07) — a sub-median reading that signals risk appetite remains intact — and the Federal Funds Rate stands at 3.63% (2026-05-07) following the Fed's measured easing cycle through Q1-Q2 2026. The 10Y-2Y Treasury spread at +48 basis points indicates a normally upward-sloping curve, post-inversion.

In this regime, the appropriate prior is that insider selling typically rises with index highs — executives rationally diversify after multi-quarter appreciation. Today's elevated dollar-sell figure ($13.51M) and depressed buy/sell ratio (0.29) are consistent with that pattern. They do not, on their own, signal late-cycle distribution. Historically, the insider buy/sell ratio compresses below 0.30 in approximately 22% of trading sessions during bull-trend regimes without serving as a leading indicator of correction.

Sector rotation signals in today's data are muted. The cleanest read is luxury-apparel weakness (ZGN cluster) and cross-border e-commerce caution (GLBE) — both consistent with the slowing-discretionary narrative driving Q1 2026 earnings revisions in those subsectors. Against this, the only meaningful conviction buy (DGICA mutual affiliate add) is in defensive P&C insurance, an established late-cycle sector preference.

For a benchmark, the long-run insider buy/sell ratio averages ~0.35 across full cycles. Readings below 0.30 occur roughly one session in five during expansionary regimes and are generally noise. Readings above 1.0 are rare and historically informative as conviction signals — today's tape is far from that threshold.

What We'Re Watching Tomorrow

1. UTHR Form 144 follow-ups. Look for subsequent Form 144 filings or amendments that would explicitly confirm 10b5-1 plan adoption dates for Rothblatt and Edgemond. Explicit 10b5-1 confirmation would close the interpretive question raised in today's Strategic Deep Dive.

2. ZGN follow-on disclosures. Watch for additional Form 4s from other Zegna board members. A fourth insider joining the cluster within 5 trading days would elevate the signal from notable to actionable.

3. GLBE 10b5-1 documentation. Any 8-K or proxy disclosure clarifying CEO Schlachet's trading plan would re-rate the conviction weight of the same-day CEO+COO sell.

4. HSBC controller follow-on. A second sell by Palomaki within 10 trading days would convert the standalone $418K print into a pattern.

5. DGICA mutual conversion narrative. Monitor Pennsylvania Department of Insurance filings and DGICA 8-Ks for mutual-to-stock conversion language. The affiliate's open-market add is the kind of tell that historically precedes such corporate-structure disclosures by 6-18 months.

6. Form 3 wave at TSM. The 15 Form 3 filings should resolve within 48 hours as routine annual director rotation. If any is associated with a board change disclosed in an 8-K, the calculus shifts.

7. Kelly Services Q2 reaction window. With four directors having received material equity awards on 2026-05-07, watch for any concurrent open-market director purchases — the latter would be the genuine conviction signal that today's grants are not.